JP2017502956A5 - - Google Patents

Download PDF

Info

Publication number
JP2017502956A5
JP2017502956A5 JP2016542948A JP2016542948A JP2017502956A5 JP 2017502956 A5 JP2017502956 A5 JP 2017502956A5 JP 2016542948 A JP2016542948 A JP 2016542948A JP 2016542948 A JP2016542948 A JP 2016542948A JP 2017502956 A5 JP2017502956 A5 JP 2017502956A5
Authority
JP
Japan
Prior art keywords
hexafluorophosphate
acid
hydrogen
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016542948A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017502956A (ja
JP6626446B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/072264 external-priority patent/WO2015100376A1/en
Publication of JP2017502956A publication Critical patent/JP2017502956A/ja
Publication of JP2017502956A5 publication Critical patent/JP2017502956A5/ja
Application granted granted Critical
Publication of JP6626446B2 publication Critical patent/JP6626446B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016542948A 2013-12-27 2014-12-23 薬学的に適切な芳香族カチオン性ペプチド Active JP6626446B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361921376P 2013-12-27 2013-12-27
US61/921,376 2013-12-27
US201461947261P 2014-03-03 2014-03-03
US61/947,261 2014-03-03
PCT/US2014/072264 WO2015100376A1 (en) 2013-12-27 2014-12-23 Pharmaceutically relevant aromatic-cationic peptides

Publications (3)

Publication Number Publication Date
JP2017502956A JP2017502956A (ja) 2017-01-26
JP2017502956A5 true JP2017502956A5 (enExample) 2018-02-08
JP6626446B2 JP6626446B2 (ja) 2019-12-25

Family

ID=53479676

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016542948A Active JP6626446B2 (ja) 2013-12-27 2014-12-23 薬学的に適切な芳香族カチオン性ペプチド

Country Status (6)

Country Link
US (2) US10221213B2 (enExample)
EP (1) EP3087093B1 (enExample)
JP (1) JP6626446B2 (enExample)
CN (2) CN112457368A (enExample)
CA (1) CA2935207C (enExample)
WO (1) WO2015100376A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112457368A (zh) * 2013-12-27 2021-03-09 康德生物医疗技术公司 药学相关的芳香族阳离子肽
SI3160984T1 (sl) 2014-06-25 2021-08-31 Flamma S.P.A. Postopek za pripravo D-arginil-2,6-dimetil-L-tirosil-L-lisil-L-fenilalaninamida
US10112976B2 (en) 2014-06-30 2018-10-30 Flamma S.P.A. Process for the production of D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide
JP6854771B2 (ja) 2015-03-06 2021-04-07 ステルス バイオセラピューティックス コープ 薬学的に適切なペプチドを調製するための方法
CA3020393A1 (en) 2016-04-11 2017-10-19 Carnot, Llc Chiral peptides
WO2018034901A1 (en) * 2016-08-16 2018-02-22 Stealth Biotherapeutics N-carboxyanhydride-based-scale synthesis of elamipretide
EP3606938A1 (en) 2017-04-05 2020-02-12 Stealth BioTherapeutics Corp Crystalline salt forms of boc-d-arg-dmt-lys-(boc)-phe-nh2
WO2019099481A1 (en) * 2017-11-15 2019-05-23 Stealth Biotherapeutics Corp. Deuterated tetrapeptides that target mitochondria
US10676506B2 (en) 2018-01-26 2020-06-09 Stealth Biotherapeutics Corp. Crystalline bis- and tris-hydrochloride salt of elamipretide
CN108929371A (zh) * 2018-08-02 2018-12-04 哈尔滨师范大学 一种Phakellistatin13直链衍生物、其制备办法及用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2067000C1 (ru) * 1994-06-29 1996-09-27 Владислав Исакович Дейгин Пептид и способ его получения
US6248716B1 (en) * 1995-06-27 2001-06-19 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US20030069231A1 (en) * 1999-10-12 2003-04-10 Klaus Rudolf Modified aminoacids, pharmaceuticals containing these compounds and method for their production
EP1294403A2 (en) * 2000-06-14 2003-03-26 Corixa Corporation Tripeptide prodrug compounds
WO2007100652A2 (en) 2006-02-22 2007-09-07 Edison Pharmaceuticals, Inc. Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US20070213505A1 (en) * 2006-03-08 2007-09-13 David Epstein Solution Synthesis of Peptide Cell Growth Stimulators
EP3040080A1 (en) 2010-03-15 2016-07-06 Stealth Peptides International, Inc. Combination therapies using cyclosporine and aromatic cationic peptides
US20150118315A1 (en) * 2011-06-14 2015-04-30 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
EP3281634A1 (en) 2012-02-22 2018-02-14 Stealth Peptides International, Inc. Method and compositions for preventing or treating ophthalmic conditions
US20130303436A1 (en) * 2012-12-06 2013-11-14 Stealth Peptides Internatioanl, Inc. Peptide therapeutics and methods for using same
US9982014B2 (en) 2013-10-23 2018-05-29 Kaneka Corporation Tetrapeptide compound and method for producing same
CN112457368A (zh) * 2013-12-27 2021-03-09 康德生物医疗技术公司 药学相关的芳香族阳离子肽
US20170081363A1 (en) * 2014-03-03 2017-03-23 Stealth Biotherapeutics Corp Pharmaceutically relevant aromatic-cationic peptides

Similar Documents

Publication Publication Date Title
JP2017502956A5 (enExample)
JP2017512762A5 (enExample)
ES2552338T3 (es) Compuestos farmacéuticos
KR101514953B1 (ko) 매크로사이클릭 화합물의 제조방법
KR101742253B1 (ko) 비페닐-2-일카르밤산의 제조방법
ES2553874T3 (es) N-Carboxialquil-auristatinas y su uso
ES2730474T3 (es) Proceso para la preparación de ivacaftor y solvatos de este
JP7450572B2 (ja) 薬学的に適切なペプチドを調製するための方法
JP7377307B2 (ja) 1-(4-(4-(3,4-ジクロロ-2-フルオロフェニルアミノ)-7-メトキシキナゾリン-6-イルオキシ)ピペリジン-1-イル)プロパ-2-エン-1-オンの製造方法
CA3090936A1 (en) Processes for the preparation of an apoptosis-inducing agent
JP2017512762A (ja) 薬学的に妥当な芳香族カチオン性ペプチド及びその生成方法
JP2016539931A (ja) テトラペプチド化合物及びその製造方法
WO2020096042A1 (ja) ジメトキシベンゼン化合物の製造方法
RU2717830C2 (ru) Способ получения азотсодержащего гетероциклического соединения и его промежуточного соединения
ES2791187T3 (es) Síntesis de dabigatrán
KR102742083B1 (ko) 디메톡시벤젠 화합물의 제조 방법
CN114667136A (zh) Trofinetide的组合物
KR20150067175A (ko) 보르테조밉을 제조하기 위한 방법
RU2009143867A (ru) Способы получения производных n-изобутил-n-(2-гидрокси-3-амино-4-фенилбутил)-пара-нитробензолсульфониламида
ES2827459T3 (es) Procedimiento para la preparación de apixaban
EP4646423A1 (en) Peptide synthesis method involving sterically hindered tri-tert-butyl-tryptophan (tbt) residue
US10329325B2 (en) Process for the preparation of (S)-4-methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxo-pentan-2-yl) amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido) pentanamide
EP2773624A1 (en) Novel process for the preparation of acylguanidines and acylthioureas
TW202328164A (zh) 加尼瑞克(ganirelix)或其鹽之製造法
Chakraborty et al. Synthesis of triazole cages containing C3-symmetric α-cyclic tripeptide scaffold